InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CYPHERPUNK TECHNOLOGIES INC.

CYPH Clue Score23
United States Fiscal year ends December CIK 0001509745 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

27
Insider
Date
Role
Action
Shares
Price
Amount
Winklevoss Capital Fund, LLC
12 Oct 2026
10% owner
Exercised, kept indirect
4,938,801
$0.00
$4.94K
William Patrick McEvoy III
12 Oct 2026
Chief Investment Officer
Exercised, kept indirect
4,938,801
$0.00
$4.94K
Khing Djien Oei
25 Sep 2026
Director
Sell
168,750
$3.92
$661.50K
Patricia A. Martin
23 Sep 2026
Director
Sell
50,000
$3.86
$193.00K
Thomas John Dietz
26 Aug 2026
Director
Sell
20,000
$1.72
$34.40K
Winklevoss Capital Fund, LLC
17 Aug 2026
10% owner
Exercised, kept indirect
16,570,852
$0.00
$16.57K
William Patrick McEvoy III
17 Aug 2026
Chief Investment Officer
Exercised, kept indirect
16,570,852
$0.00
$16.57K
Christopher Mirabelli
26 Mar 2026
Director
Sell
60,000
$0.71
$42.63K
Douglas E Onsi
17 Nov 2025
CEO,CFO,Pres.,GC,Treas.&Sec.
Sell indirect
414,479
$3.14
$1.30M
Douglas E Onsi
17 Nov 2025
CEO,CFO,Pres.,GC,Treas.&Sec.
Sell indirect
261,840
$3.14
$822.18K
James H Cavanaugh
17 Nov 2025
Director
Sell indirect
261,840
$3.14
$822.18K
Christopher Mirabelli
17 Nov 2025
Director
Sell indirect
414,479
$3.14
$1.30M
Christopher Mirabelli
17 Nov 2025
Director
Sell indirect
261,840
$3.14
$822.18K
Christopher Mirabelli
13 Nov 2024
Chairman of the Board
Exercised, kept indirect
2,136
$2.82
$6.02K
Augustine Lawlor
13 Nov 2024
Chief Operating Officer
Exercised, kept indirect
2,136
$2.82
$6.02K
Douglas E Onsi
13 Nov 2024
CEO,CFO,Pres.,GC,Treas.&Sec.
Exercised, kept indirect
2,136
$2.82
$6.02K
James H Cavanaugh
13 Nov 2024
Director
Exercised, kept
213
$2.82
$600.66
BeiGene, Ltd.
24 Sep 2021
10% owner
Buy
2,543,800
$2.85
$7.25M
Perceptive Advisors LLC
22 Jun 2020
10% owner
Buy indirect
1,750,000
$2.00
$3.50M
HealthCare Ventures IX, L.P.
5 Feb 2019
10% owner
Buy
571,428
$1.75
$1,000.00K
Christopher Mirabelli
5 Feb 2019
CEO, President, Chairman
Buy indirect
571,428
$1.75
$1,000.00K
Augustine Lawlor
5 Feb 2019
Chief Operating Officer
Buy indirect
571,428
$1.75
$1,000.00K
Douglas E Onsi
5 Feb 2019
CFO, GC, Treasurer & Secretary
Buy indirect
571,428
$1.75
$1,000.00K
Augustine Lawlor
14 Nov 2017
Chief Operating Officer
Buy indirect
1,057,769
$6.09
$6.44M
Christopher Mirabelli
14 Nov 2017
CEO, President, COB
Buy indirect
1,057,769
$6.09
$6.44M
HealthCare Ventures IX, L.P.
14 Nov 2017
10% owner
Buy
1,057,769
$6.09
$6.44M
Douglas E Onsi
14 Nov 2017
CFO, GC, Treasurer & Secretary
Buy indirect
1,057,769
$6.09
$6.44M

What was left out

Form 4 filings counted 262
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 48,274,562
History held since 23 Jan 2017